B. Riley raised the firm’s price target on Cinemark (CNK) to $34 from $30 and keeps a Neutral rating on the shares. Industry box office revenue rose 22% year over year in the period, outperforming expectations and driven by strong releases in March, particularly Project Hail Mary, alongside solid contributions from Scream 7 and Hoppers, the analyst tells investors in a research note. Looking ahead to Q2, box office is expected to grow slightly, with gains in June offset by weaker April and May comparisons and mixed revisions to key film assumptions, the firm says.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK:
- Cinemark price target raised to $34 from $30 at B. Riley
- Ellison commits to 45-day movie release window, Variety reports
- Cinemark price target raised to $36 from $32 at Wells Fargo
- Cinemark price target raised to $35 from $31 at JPMorgan
- Cinemark achieves all-time high five-day Easter weekend box office